Boston Scientific’s stock climbs on Q3 sales and earnings beat
Boston Scientific’s BSX net income was $469 million, or 32 cents a share, down from $505 million, or 34 cents a share, in the same period last year. On an adjusted basis, Boston Scientific reported earnings of 63 cents a share, above the FactSet consensus of 59 cents a share.
Boston Scientific reported third-quarter results that came in ahead of the consensus forecast, raising its 2024 guidance ...
Key Takeaways Boston Scientific shares fell Wednesday as its third-quarter profit missed estimates.The medical device maker's ...
On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter revenues of $4.21 billion, beating the ...
The med-tech company with approximately 9,400 employees in Minnesota posted profit and sales that beat Wall Street’s ...
RBC Capital raised the firm’s price target on Boston Scientific (BSX) to $98 from $95 and keeps an Outperform rating on the shares. The ...
21h
Good morning, Boston. Here are the five things you need to know in local business news to start your busy Thursday.
Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing ...
William Plovanic, an analyst from Canaccord Genuity, maintained the Buy rating on Boston Scientific (BSX – Research Report). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback